0001484612-23-000032.txt : 20230505
0001484612-23-000032.hdr.sgml : 20230505
20230505181123
ACCESSION NUMBER: 0001484612-23-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230503
FILED AS OF DATE: 20230505
DATE AS OF CHANGE: 20230505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trigg Leslie
CENTRAL INDEX KEY: 0001304125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 23895338
MAIL ADDRESS:
STREET 1: C/O OUTSET MEDICAL
STREET 2: 1830 BERING ROAD
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-03
0
0001484612
Outset Medical, Inc.
OM
0001304125
Trigg Leslie
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
1
1
0
0
Chair and CEO
1
Common Stock
2023-05-03
4
M
0
20000
4.11
A
432451
D
Common Stock
2023-05-03
4
S
0
20000
20.009
D
412451
D
Common Stock
2023-05-03
4
M
0
9492
4.11
A
421943
D
Common Stock
2023-05-03
4
S
0
9492
20.0
D
412451
D
Common Stock
2023-05-03
4
M
0
10508
3.88
A
422959
D
Common Stock
2023-05-03
4
S
0
10508
20.0
D
412451
D
Common Stock
8770
I
Trigg Family Trust
Performance Options (right to buy)
3.88
2023-05-03
4
M
0
10508
0.0
D
2027-09-19
Common Stock
10508
0
D
Performance Options (right to buy)
4.11
2023-05-03
4
M
0
20000
0.0
D
2028-11-03
Common Stock
20000
94910
D
Performance Options (right to buy)
4.11
2023-05-03
4
M
0
9492
0.0
D
2028-11-03
Common Stock
9492
85418
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.
The price reported in Column 4 is a weighted average price. The 20,000 shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$20.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
By: John L Brottem For: Leslie Trigg
2023-05-05